ArticleJournal of nanobiotechnology2026
Pathogen-microenvironment-responsive and antioxidant-buffered propiconazole nanofungicide for safe and effective fungal disease control.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanotechnology-driven strategies to overcome azole resistance inFrontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Although fungicide application via unmanned aerial vehicle (UAV) is increasingly used and has proven effective, concentrated deposition of fungicides can lead to phytotoxicity. Here, we developed Pro@CS/PQ, a nanofungicide comprising a chitosan (CS) core loaded with propiconazole (Pro) and a pectin–quercetin conjugate (PQ) shell. This dual-functional platform combines on-demand release with antioxidant buffering. Pro@CS/PQ released propiconazole more rapidly under acidic or pectinase-rich conditions, reaching 87.4% cumulative release within 72 h. Quercetin simultaneously protects plant tissues from oxidative stress and maintains redox homeostasis under excessive fungicide exposure. Compared with propiconazole emulsifiable concentrate (Pro EC), Pro@CS/PQ showed enhanced antifungal activity against Rhizoctonia solani, Fusarium fujikuroi, Botrytis cinerea, and Magnaporthe oryzae. In detached rice leaves infected with R. solani, Pro@CS/PQ at 50 mg·L⁻¹ achieved protective and curative efficacies of 85.8% and 70.8%, which were significantly higher than those of Pro EC. Pro@CS/PQ also exhibited improved foliar adhesion, maintaining over 60% leaf retention after water washing, approximately twice the retention of Pro EC. At concentrations up to four times the recommended rate, Pro@CS/PQ caused no visible phytotoxicity, whereas Pro EC induced severe leaf damage at half that concentration. Metabolomic analysis confirmed that Pro@CS/PQ mitigated propiconazole-induced metabolic perturbations and preserved homeostasis of key metabolic pathways involving amino acids, carbohydrates, and pyrimidines. This work offers a promising solution for safe and effective application of triazole fungicides.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.